Latest Insights - page 31 | BiopharmaTrend

HP and Tecan Launch Combined Single-Cell and Reagent Dispenser, Report 40x Faster Dosing for Drug Discovery

HP and Tecan have launched the Duo Digital Dispenser, a system that combines single-cell isolation and reagent dispensing in one unit. According to the companies, the system leverages HP’s inkjet …

Continue ›››

Experity Rolls Out AI-Integrated Partner Ecosystem to Streamline Urgent Care Operations

Experity has launched a Partner Ecosystem aimed at integrating AI-based tools into urgent care operations. The initiative, announced this week, expands the company's software infrastructure to accommodate third-party solutions across …

Continue ›››

AI Model Reconstructs 3D Human Faces from DNA with High Accuracy

A new study has introduced Difface, an AI-based framework capable of reconstructing 3D human facial images directly from DNA, demonstrating high fidelity in linking genetic variants to phenotypic facial features. …

Continue ›››

Boehringer Ingelheim Taps Tempus’ AI and Patient Data to Deepen Cancer Research Pipeline

Tempus has entered a strategic multi-year collaboration with Boehringer Ingelheim to support the expansion of Boehringer’s oncology pipeline using AI and multimodal real-world data. The announcement formalizes years of earlier …

Continue ›››

AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch

Today, clinical trials are longer and more data-heavy than a decade ago. At a time of regulatory rethinking, we trace how AI is beginning to orchestrate trial workflows. To know …

Continue ›››

Regeneron Acquires 23andMe Assets for $256M to Expand Consumer Genomics and Data-Driven Drug Discovery

Regeneron has announced an agreement to acquire substantially all assets of 23andMe for $256 million, following a bankruptcy auction process. The transaction, expected to close in Q3 2025 pending court …

Continue ›››

Oracle Rebuilds Its EHR Infrastructure to Support AI-Native Workflows

Oracle has launched a new electronic health record (EHR) platform that diverges entirely from the architecture of Cerner, which it acquired in 2022 for $28 billion. As reported by CNBC, …

Continue ›››

CRISPR Therapy Saves Infant With Rare Genetic Disorder

Doctors at Children’s Hospital of Philadelphia have reported a breakthrough use of CRISPR gene editing to treat an infant with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare and …

Continue ›››

Researchers Use Terahertz Imaging for First-Ever 3D View of Cochlea Without Surgery

In a study published March 27 in Optica, researchers from Waseda, Kobe, and Osaka Universities reported the successful use of terahertz (THz) imaging to non-invasively visualize the internal structure of …

Continue ›››

Medable Updates Digital Platform With Oncology-Focused Tools Ahead of ASCO 2025

Medable has announced the release of a new version of its digital clinical trials platform tailored specifically for oncology, ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting. …

Continue ›››

Absci Doses First Participants in Phase 1 Trial of AI-Designed Antibody for IBD

Absci has announced the dosing of the first participants in a Phase 1 trial of ABS-101, an investigational antibody for inflammatory bowel disease (IBD) designed using its generative AI platform. …

Continue ›››

Eligo Bioscience Gets $5M Grant to Advance Gene-Editing Skin Therapy Using Bacteria

The funding supports development of Eligo’s topical gene delivery system, which programs skin-resident bacteria to locally produce therapeutic biologics.

Continue ›››